Hepatitis C Division

[Anonymous]

Wall Street projects >$3 Billion annual for AbbVie HCV regimen!!! Bright future for new hires to Division!

Yes, always trust Wall Street. Think Enron!!

 

[Anonymous]

Yes, always trust Wall Street. Think Enron!!

Hey Little Mr. Sunshine it must be hard living a life of negativity! Do you still listen to bands like Nirvana, Mother Love Bone, Alice in Chains? Lighten up and be POSITIVE and GOOD THINGS will come your way!

 

[Anonymous]

Wall Street projects >$3 Billion annual for AbbVie HCV regimen!!! Bright future for new hires to Division!

Not sure I want to jump to this ship until it is approved. Would not be the first time a HCV drug has failed.

 

[Anonymous]

Hey Little Mr. Sunshine it must be hard living a life of negativity! Do you still listen to bands like Nirvana, Mother Love Bone, Alice in Chains? Lighten up and be POSITIVE and GOOD THINGS will come your way!

It's Ms. Sunshine, to you. Ms. Sunshine and Lollipops, to be more accurate. Can you please send me an invite to your cult so I can get all positive? I am open to all cults and other solutions. Thx.

 

[Anonymous]

Not sure I want to jump to this ship until it is approved. Would not be the first time a HCV drug has failed.

Will SUCEED in getting approved but FAIL in market.

BID vs QD
12 vs. 8-12 weeks
Ritonovir vs. no extra DDI
Pill burden etc.....

 

[Anonymous]

It's Ms. Sunshine, to you. Ms. Sunshine and Lollipops, to be more accurate. Can you please send me an invite to your cult so I can get all positive? I am open to all cults and other solutions. Thx.

Little Ms. Sunshine: Read the following and smile: "The $70 billion company AbbVie (NYSE: ABBV) also has three breakthrough therapy designations awarded to its Phase 3 hepatitis C candidate, known as DAA combination with and without ribavirin. AbbVie’s HCV product has been tested on 571 patients in a trial called “Aviator,” where a high viral response rate was identified after 12 weeks of treatment. What makes this product special is that it treats both patients who have failed prior treatments, and those who are untreated. According to Reuters, this product could produce annual sales north of $3 billion, which would be a nice addition to AbbVie’s $18.3 billion in sales last year."

 

[Anonymous]

Little Ms. Sunshine: Read the following and smile: "The $70 billion company AbbVie (NYSE: ABBV) also has three breakthrough therapy designations awarded to its Phase 3 hepatitis C candidate, known as DAA combination with and without ribavirin. AbbVie’s HCV product has been tested on 571 patients in a trial called “Aviator,” where a high viral response rate was identified after 12 weeks of treatment. What makes this product special is that it treats both patients who have failed prior treatments, and those who are untreated. According to Reuters, this product could produce annual sales north of $3 billion, which would be a nice addition to AbbVie’s $18.3 billion in sales last year."

I read it already. I will be impressed when it beats Gilead in the marketplace. Recommendation: Always make sure to read competitor updates. It is best to know all the facts when making decisions on which way to display emotion. You can also call me INTP! Now business groups state INTP and INTJ personalities are best in leadership positions. I apologize if I am not a touchy feely HR rep. Sue me for not jumping up and down and waving my pom poms. Ugh. Ugh. Ugh. Just let me do my work; don't ask me to feel all this crapola.

 

[Anonymous]

I read it already. I will be impressed when it beats Gilead in the marketplace. Recommendation: Always make sure to read competitor updates. It is best to know all the facts when making decisions on which way to display emotion. You can also call me INTP! Now business groups state INTP and INTJ personalities are best in leadership positions. I apologize if I am not a touchy feely HR rep. Sue me for not jumping up and down and waving my pom poms. Ugh. Ugh. Ugh. Just let me do my work; don't ask me to feel all this crapola.

I am sorry that you are such a bitter and lonely person Ms. Sunshine. Maybe you need a man in your life, honey.

 

[Anonymous]

Abbvie is one liver away from never launching.

 

[Anonymous]

Are you in need of a liver transplant due to all the booze and drugs and tattoos you did?

 

[Anonymous]

I am sorry that you are such a bitter and lonely person Ms. Sunshine. Maybe you need a man in your life, honey.

Comments like this make it clear you are a sexist so you must be AbbVie HR. My man thinks so, too.

 

[Anonymous]

Are you in need of a liver transplant due to all the booze and drugs and tattoos you did?

No, but i may be in need of a liver transplant from taking all those abbvie/abbott drugs. Any donors out there? Howz about we scrap the severance and get me a new liver instead?

 

[Anonymous]

Comments like this make it clear you are a sexist so you must be AbbVie HR. My man thinks so, too.

I feel sorry for you Man!! You must be as much fun as a dead fish!

 

[Anonymous]

I feel sorry for you Man!! You must be as much fun as a dead fish!

What a loser. Boring. Yawn.

 

[Anonymous]

Have you read our data? I have and I think we are gonna be super competitive like 40% share if all goes well. Can't wait!

 

[Anonymous]

Have you read our data? I have and I think we are gonna be super competitive like 40% share if all goes well. Can't wait!

"Waiting for Godot."? "The Iceman Cometh". Just some recommended reading while you wait. Enjoy.

 

[Anonymous]

Have you read our data? I have and I think we are gonna be super competitive like 40% share if all goes well. Can't wait!

Me too drug. As in 2 pills. They are always real blockbusters! I'm thinking that the drawback of intellectual property theft is that it doesn't always pay off because of the timing. Whatdyou think?

 

[Anonymous]

"Waiting for Godot."? "The Iceman Cometh". Just some recommended reading while you wait. Enjoy.

You should read journal articles a little more

 

[Anonymous]

I would not get excited about 14 or 26 patients receiving a cure. Let's see a ph3 trial will a substantial n so that we can extrapolate to the target population... minority, HIV pos with stage 2 liver damage. Those are the people looking for a "cure", and a current ph 2 n of under 30 in a clinical trial is ridiculous to get all giddy about.

 

[Anonymous]

I would not get excited about 14 or 26 patients receiving a cure. Let's see a ph3 trial will a substantial n so that we can extrapolate to the target population... minority, HIV pos with stage 2 liver damage. Those are the people looking for a "cure", and a current ph 2 n of under 30 in a clinical trial is ridiculous to get all giddy about.

Hey professor
You are the problem here. Sometimes you just need passion but guess you you require a glossy wall st detailer right?